Related Experiment Video
Updated: Aug 29, 2025

09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
Identifying Actionable Variants in Cancer - The Dual Web and Batch Processing Tool MTB-Report.
Nadine S Kurz1, Júlia Perera-Bel2, Charlotte Höltermann1
1Dept. of Medical Bioinformatics, University Medical Center Göttingen, Germany.
Studies in Health Technology and Informatics
|September 8, 2022
Summary
Interpreting cancer genomic variants is challenging. The MTB-Report tool automates variant annotation and filtering, aiding precision oncology and molecular tumor boards in identifying actionable targets and therapies.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Next-generation sequencing (NGS) generates vast amounts of genomic variant data in cancer.
- Manual interpretation of these variants for precision oncology is time-consuming and does not scale.
- Clinical decision-making in molecular tumor boards requires efficient data analysis tools.
Purpose of the Study:
- To develop a computational tool for annotating, filtering, and sorting cancer genomic variants.
- To provide evidence for actionable variants to support precision oncology and molecular tumor boards.
- To create a user-friendly application for both clinical and research settings.
Main Methods:
- The MTB-Report tool integrates public genomic databases for variant annotation.
- It offers a web interface for interactive use and a command-line mode for batch processing.
- The tool is implemented in R and provided as a Docker image for easy deployment and reproducibility.
Main Results:
- MTB-Report annotates, filters, and sorts genetic variants, highlighting actionable targets.
- It supports clinicians in molecular tumor boards and researchers analyzing large datasets.
- Containerization ensures stable, reproducible results.
Conclusions:
- MTB-Report addresses the need for automated analysis of large-scale genomic data in cancer.
- The tool enhances efficiency and reproducibility in identifying therapeutic targets.
- It facilitates data-driven decision-making in precision oncology and clinical practice.
Keywords:
Variant interpretationactionable variantsmolecular profilesmolecular tumor boardnext-generation sequencingprecision oncology
